Literature DB >> 8477801

Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin-dependent diabetes mellitus.

K S Rønningen1, D E Undlien, R Ploski, N Maouni, R J Konrad, E Jensen, E Hornes, H Reijonen, M Colonna, D S Monos.   

Abstract

The TAP1 and TAP2 genes, located in the HLA class II region, encode subunits of a peptide transporter. Both genes display limited genetic variability; four different nucleotide substitutions have been found in the TAP2 gene. Here studies on linkage disequilibrium between TAP2 variants and HLA class II alleles are reported, in an attempt to evaluate whether TAP2 variants are associated with insulin-dependent diabetes mellitus (IDDM). As reported previously, a significant decrease of homozygosity for TAP2 alleles encoding alanine at residue 665 (665 Ala) and glutamine at 687 (687 Gln) paralleled by an increase in homozygosity for TAP2 alleles encoding threonine at residue 665 (665 Thr) and a stop codon at 687 (687 Stop), was found in both Finnish and Norwegian IDDM patients compared to random controls. However, a strong linkage disequilibrium between these TAP2 polymorphisms and given HLA-DR and -DQ genes was observed among healthy controls. The frequent 665 Thr and 687 Stop variants were in linkage disequilibrium both with the DR4-DQ8 and the DR3-DQ2 haplotypes, haplotypes which are strongly associated with IDDM. In contrast, the DR1-DQ5 and DR13-DQ6 (e.g. DQB1*0603) haplotypes, which are decreased among IDDM patients, were associated with the 665 Ala and 687 Gln variants. Thus, when DR- and DQ-matched patients and controls were compared, associations of the investigated TAP2 variants and IDDM were no longer detectable. These data, therefore, indicate that the associations previously found between certain TAP2 variants and IDDM are secondary to a primary association between this disease and particular DQ alpha beta heterodimers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477801     DOI: 10.1002/eji.1830230511

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

Review 1.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.

Authors:  J Piniés; L Castaño; P Colman
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

Review 3.  Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.

Authors:  Y Yang; P Sempé; P A Peterson
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 4.  The genes influencing the susceptibility to IDDM in humans.

Authors:  S Faas; M Trucco
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

5.  A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B.

Authors:  H M Diepolder; M C Jung; E Keller; W Schraut; J T Gerlach; N Grüner; R Zachoval; R M Hoffmann; C A Schirren; S Scholz; G R Pape
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

6.  Differential contribution of HLA-DR, DQ, and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients: role of TAP2*01 alleles in Ro autoantibody production.

Authors:  J M Martín-Villa; J Martínez-Laso; M A Moreno-Pelayo; M J Castro-Panete; N Martínez-Quiles; M Alvarez; M D de Juan; J J Gómez-Reino; A Arnaiz-Villena
Journal:  Ann Rheum Dis       Date:  1998-04       Impact factor: 19.103

7.  Genetic susceptibility to type 1 diabetes in the intracellular pathway of antigen processing - a subject review and cross-study comparison.

Authors:  Charles Sia; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2005-05-10

8.  A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.

Authors:  James R Cerhan; Zachary S Fredericksen; Anne J Novak; Stephen M Ansell; Neil E Kay; Mark Liebow; Ahmet Dogan; Julie M Cunningham; Alice H Wang; Thomas E Witzig; Thomas M Habermann; Yan W Asmann; Susan L Slager
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-21       Impact factor: 4.254

9.  Polymorphisms of the TAP2 transporter gene in systemic lupus erythematosus.

Authors:  E J Davies; R P Donn; M C Hillarby; D M Grennan; W E Ollier
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

10.  HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: no evidence for an additional contribution to disease risk by the TAP2 locus.

Authors:  L Esposito; V Lampasona; E Bosi; F Poli; M Ferrari; E Bonifacio
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.